Links

© 2018 Chengdu Gaotong Isotope Co., Ltd.(CNNC) All rights reserved.

Our History

Our story started when Nuclear Power Institute of China started research of isotopes In the 1970s. After the successful transition in the early 2000s, Chengdu Gaotong Isotope maintained our leading role in the industry as a member of CIRC.

1

2014

Obtained GMP recertification for radiopharmaceutical production facilities.

 

2012

Built the Instant-Labeled Drug Center together with HTA. Co. Ltd.

 

2011

China Isotope & Radiation Corporation was established as CNNC’s nuclear technology application platform . It has since become the biggest shareholder of Chengdu Gaotong Isotope.

 

2010

Obtained certificate of approval for the quality, environment, and occupational health and safety management system

 

2009

Strontium [Sr-89] Chloride Injection was listed as an important provincial project of Sichuan by the authority.

 

2008

Obtained regulatory approval for Strontium Chloride [Sr-89] injection and 3 types of B(U) containers from China Food and Drug Administration and China Nuclear Safety Administration.

 

2004

New production facility of Sodium Iodine [I-131] Oral Solution was set up

 

2003

Obtained GMP certificate for radiopharmaceutical production facilities.

 

2002

Chengdu Gaotong Isotope Co., Ltd. (CNNC) was established.

 

1999

Low-activity sealed radioactive source production facility was set up.

 

1996

Developed dry distillation process to produce I-131; Production facility of the said process was set up.

1986

The radiopharmaceutical production facilities were set up by NPIC. The first commercial gel-type Tc-99m generator production facility in the world was built and became an IAEA demonstration project.

 

1981

The first sealed radioactive source production facility with the capability of one million curies of Co-60 was set up in China.

 

1972

NPIC began R&D of sealed radioactive sources.

 

1971

NPIC began R&D of radiopharmaceuticals.